Filing Details

Accession Number:
0001209191-18-055385
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-17 17:32:11
Reporting Period:
2018-10-15
Accepted Time:
2018-10-17 17:32:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1737287 Allogene Therapeutics Inc. ALLO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1548072 B Franz Humer 210 East Grand Avenue
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-15 30,000 $18.00 30,000 No 4 P Direct
Common Stock Acquisiton 2018-10-15 74,870 $0.00 104,870 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2018-10-15 14,261 $0.00 74,870 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. The Series A Convertible Preferred Stock converted on a 5.25-for-1 basis and had no expiration date.